Prospective longitudinal assessment of late anthracycline cardiotoxicity after childhood cancer: the role of diastolic function
- PMID: 15367528
- PMCID: PMC1768494
- DOI: 10.1136/hrt.2003.027516
Prospective longitudinal assessment of late anthracycline cardiotoxicity after childhood cancer: the role of diastolic function
Figures
References
-
- Sorensen K , Levitt G, Sebag-Montefiore D, et al. Cardiac function in Wilms’ tumor survivors. J Clin Oncol 1995;13:1546–56. - PubMed
-
- Rammeloo LAJ, Postma A, Sobotka-Plojhar MA. Low-dose daunorubicin in induction treatment of childhood acute lymphoblastic leukemia: no long-term cardiac damage in a randomised study of the Dutch childhood leukemia study group. Med Ped Oncol 2000;35:136–9. - PubMed
-
- Sorensen K , Levitt G, Bull C, et al. Anthracycline dose in childhood acute lymphoblastic leukaemia: issues of early survival versus late cardiotoxicity. J Clin Oncol 1997;15:61–8. - PubMed
-
- Sorensen K , Levitt GA, Bull C, et al. Late anthraracycline cardiotoxicity after childhood cancer. A prospective longitudinal study. Cancer 2003;97:1991–8. - PubMed
-
- Bu’Lock FA, Mott MG, Oakhill A, et al. Left ventricular diastolic filling patterns associated with progressive anthracycline-induced myocardial damage: a prospective study. Pediatr Cardiol 1999;20:252–63. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources